Patent Assignment
Reel/Frame 053034/0018
Release of Security Interest
Recorded: 2020-06-24
Pages: 8
Assignor
OXFORD FINANCE LLC, AS COLLATERAL AGENT
Executed: 2020-06-24
Assignee
REATA PHARMACEUTICALS, INC.
5320 LEGACY DRIVE, PLANO, TEXAS, 75024
Covered Properties
(57)
Methods of Treating Obesity Using Antioxidant Inflammation Modulators
Natural Product Analogs Including an Anti-Inflammatory Cyanoenone Pharmacore and Methods of Use
Application:
15/791,677 →
Publication:
US 2018/0237383
Pyrazolyl and Pyrimidinyl Tricyclic Enones as Antioxidant Inflammation Modulators
Application:
15/861,758 →
Publication:
US 2018/0265455
C17-Heteroaryl Derivatives of Oleanolic Acid and Methods of Use Thereof
Methods of Treating and Preventing Endothelial Dysfunction Using Bardoxolone Methyl or Analogs Thereof
Application:
14/466,495 →
Publication:
US 2015/0080465
C17-Alkanediyl and Alkenediyl Derivatives of Oleanolic Acid and Methods of Use Thereof
Imidazolyl Tricyclic Enones as Antioxidant Inflammation Modulators
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
2,2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
Synthetic Triterpenoids and Methods of Use in the Treatment of Disease
Application:
15/675,862 →
Publication:
US 2018/0161311
C4-Modified Oleanolic Acid Derivatives for Inhibition of Il-17 and Other Uses
Co-crystal Forms of a Novobiocin Analog and Proline
Application:
62/627,570 →
Biaryl Amides with Modified Sugar Groups for Treatment of Diseases Associated with Heat Shock Protein Pathway
Application:
62/671,047 →
Methods of Treating Alport Syndrome Using Bardoxolone Methyl or Analogs Thereof
Application:
62/535,663 →
Methods of Treating Alport Syndrome Using Bardoxolone Methyl or Analogs Thereof
Application:
62/580,597 →
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Adjustable Round Cable Slitter
Application:
16/130,424 →
Publication:
US 2019/0137719
Methods of Treating and Preventing Endothelial Dysfunction Using Bardoxolone Methyl or Analogs Thereof
Application:
16/157,225 →
Publication:
US 2019/0091194
Novel Forms of Cddo Methyl Ester
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Saturation in the C-Ring
Antioxidant Inflammation Modulators: C-17 Homologated Oleanolic Acid Derivatives
Antioxidant Inflammation Modulators: Novel Derivatives of Oleanolic Acid
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Saturation in the C-Ring
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Dehydroandrosterone Analogs Including an Anti-Inflammatory Pharmacore and Methods of Use
Novel Forms of Cddo Methyl Ester
Antioxidant Inflammation Modulators: Novel Derivatives of Oleanolic Acid
Antioxidant Inflammation Modulators: C-17 Homologated Oleanolic Acid Derivatives
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Saturation in the C-Ring
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Pyrazolyl and Pyrimidinyl Tricyclic Enones as Antioxidant Inflammation Modulators
Novel Forms of Cddo Methyl Ester
Delayed Release, Oral Dosage Compositions That Contain Amorphous Cddo-Me
2,2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Saturation in the C-Ring
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Delayed Release, Oral Dosage Compositions That Contain Amorphous Cddo-Me
Pyrazolyl and Pyrimidinyl Tricyclic Enones as Antioxidant Inflammation Modulators
Natural Product Analogs Including an Anti-Inflammatory Cyanoenone Pharmacore and Methods of Use
Antioxidant Inflammation Modulators: C-17 Homologated Oleanolic Acid Derivatives
C13-Hydroxy Derivatives of Oleanolic Acid and Methods of Use Thereof
C4 Monomethyl Triterpenoid Derivatives and Methods of Use Thereof
Aryl and Arylalkyl Substituted Pyrazolyl and Pyrimidinyl Tricyclic Enones as Antioxidant Inflammation Modulators
C17-Heteroaryl Derivatives of Oleanolic Acid and Methods of Use Thereof
A-Ring Epoxidized Triterpenoid-Based Anti-Inflammation Modulators and Methods of Use Thereof
C17-Alkanediyl and Alkenediyl Derivatives of Oleanolic Acid and Methods of Use Thereof
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
2,2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
Natural Product Analogs Including an Anti-Inflammatory Cyanoenone Pharmacore and Methods of Use
Pyrazolyl and Pyrimidinyl Tricyclic Enones as Antioxidant Inflammation Modulators
C17-Heteroaryl Derivatives of Oleanolic Acid and Methods of Use Thereof
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Saturation in the C-Ring
Patent:
45,288 →
Application:
14/080,267 →
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Saturation in the C-Ring
Patent:
45,325 →
Application:
14/080,414 →
Synthetic Triterpenoids and Methods of Use in the Treatment of Disease
Synthetic Triterpenoids and Methods of Use in the Treatment of Disease
Synthetic Triterpenoids and Methods of Use in the Treatment of Disease
Betulinic Acid Derivatives and Methods of Use Thereof
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 28, 2008
From: WALLING, JOHN; PARENT, STEPHAN D.; JONAITIS, DAVID T.; KRAL, ROBERT M., JR.
To: REATA PHARMACEUTICALS INC.
Reel/Frame 021750/0176 →
Assignment of Assignor's Interest
Sep 11, 2009
From: ANDERSON, ERIC; JIANG, XIN; LIU, XIAOFENG; VISNICK, MELEAN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 023217/0522 →
Assignment of Assignor's Interest
Sep 11, 2009
From: JIANG, XIN; LIU, XIAOFENG; VISNICK, MELEAN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 023219/0305 →
Assignment of Assignor's Interest
Sep 11, 2009
From: J-STAR RESEARCH, INC.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 023218/0796 →
Assignment of Assignor's Interest
Sep 11, 2009
From: GREINER, JACK; MARAVETZ, LESTER L.; SZUCS, STEPHEN S.
To: J-STAR RESEARCH, INC.
Reel/Frame 023218/0737 →
Assignment of Assignor's Interest
Sep 11, 2009
From: JIANG, XIN; VISNICK, MELEAN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 023218/0564 →
Assignment of Assignor's Interest
Sep 11, 2009
From: J-STAR RESEARCH, INC.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 023219/0638 →
Assignment of Assignor's Interest
Sep 11, 2009
From: GREINER, JACK; SZUCS, STEPHEN S.
To: J-STAR RESEARCH, INC.
Reel/Frame 023219/0586 →
Corrective Assignment to Correct the Misspelling of the Address of the Assignee Previously Recorded on Reel 023218 Frame 0737. Assignor(S) Hereby Confirms the Their Entire Right Disclosed in Serial No. 12/426,791, Which Has Been Filed on April 20, 2009...
Oct 14, 2009
From: GREINER, JACK; MARAVETZ, LESTER L.; SZUCS, STEPHEN S.
To: J-STAR RESEARCH, INC.
Reel/Frame 023370/0174 →
Assignment of Assignor's Interest
Jun 10, 2011
From: MEYER, COLIN J.; HUFF, WARREN
To: REATA PHARMACEUTICALS
Reel/Frame 026427/0698 →
Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 026427 Frame 0698. Assignor(S) Hereby Confirms the the Entire Right, Title, and Interest for the United States and All Foreign Countries in and to Any and All Improvements.
Aug 23, 2012
From: MEYER, COLIN J.; HUFF, J. WARREN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 028840/0735 →
Assignment of Assignor's Interest
Oct 2, 2014
From: CHIN, MELANIE PEI-HENG; MEYER, COLIN J.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 033869/0469 →
Assignment of Assignor's Interest
Feb 15, 2017
From: BENDER, CHRISTOPHER F.; JIANG, XIN; ANDERSON, ERIC; VISNICK, MELEAN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 041260/0626 →
Assignment of Assignor's Interest
Jun 6, 2017
From: ANDERSON, ERIC; JIANG, XIN; VISNICK, MELEAN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 042618/0601 →
Assignment of Assignor's Interest
Jun 14, 2017
From: ANDERSON, ERIC; LIU, XIAOFENG
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 042707/0280 →
Assignment of Assignor's Interest
Jun 14, 2017
From: DECKER, ANDREA
To: SOLVIAS AG
Reel/Frame 042707/0431 →
Assignment of Assignor's Interest
Jun 14, 2017
From: SOLVIAS AG
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 042707/0556 →
Assignment of Assignor's Interest
Aug 1, 2017
From: MEYER, COLIN J.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 043151/0155 →
Assignment of Assignor's Interest
Aug 14, 2017
From: KRAL, ROBERT M.; MEYER, COLIN J.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 043278/0640 →
Assignment of Assignor's Interest
Aug 14, 2017
From: SPORN, MICHAEL B.; LIBY, KAREN T.; GRIBBLE, GORDON W.; HONDA, TADASHI
To: TRUSTEES OF DARTMOUTH COLLEGE
Reel/Frame 043539/0424 →
Assignment of Assignor's Interest
Sep 13, 2017
From: JIANG, XIN; BENDER, CHRISTOPHER F.; VISNICK, MELEAN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 043571/0151 →
Assignment of Assignor's Interest
Sep 13, 2017
From: CAPRATHE, BRADLEY WILLIAM; LEE, CHITASE; BOLTON, GARY
To: AAPHARMASYN LLC
Reel/Frame 043570/0838 →
Assignment of Assignor's Interest
Sep 13, 2017
From: AAPHARMASYN LLC
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 043571/0005 →
Assignment of Assignor's Interest
Oct 24, 2017
From: AAPHARMASYN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 043934/0860 →
Assignment of Assignor's Interest
Oct 24, 2017
From: ANDERSON, ERIC; FERGUSON, DEBORAH A.; JIANG, XIN; KRAL, ROBERT M., JR.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 043934/0579 →